Influenza Screening: Could a Taste-Based Sensor Play a Role?
Selective methylation of N-acetylneuraminic acid enabled a taste-releasing sensor to distinguish influenza neuraminidase from bacterial enzymes
-
By
-
Kathryn Wighton
-
January 13, 2026
-
Clinical Scorecard: Influenza Screening: Could a Taste-Based Sensor Play a Role?
At a Glance
| Category | Detail |
|---|
| Condition | Influenza |
| Key Mechanisms | Taste-based sensor utilizing viral neuraminidase activity to cleave a chemically engineered sensor. |
| Target Population | Patients with influenza, particularly those hospitalized and influenza-positive. |
| Care Setting | Point of care testing. |
Key Highlights
- Development of a taste-based sensor that selectively responds to viral neuraminidase.
- Methylated α-linked sensor demonstrated selectivity for viral neuraminidase over bacterial neuraminidase.
- Neuraminidase activity in saliva from influenza-positive patients was sufficient to activate the sensor.
- Cytotoxicity testing showed no reduction in cell viability at concentrations up to 1.0 mM.
- Sensor stability maintained at least 95% integrity for four weeks under typical storage conditions.
Guideline-Based Recommendations
Diagnosis
- Utilize the taste-based sensor for early detection of influenza through neuraminidase activity.
Management
- Consider the sensor as a low-cost, rapid testing option at the point of care.
Monitoring & Follow-up
- Assess neuraminidase levels in saliva to evaluate sensor activation potential.
Risks
- Further assessment needed against patient-reported outcomes to validate clinical utility.
Patient & Prescribing Data
Hospitalized patients with confirmed influenza.
Milligram-level quantities of sensor estimated for effective oral use.
Clinical Best Practices
- Monitor neuraminidase activity in patients to guide sensor use.
- Ensure sensor selectivity is maintained for accurate influenza detection.
Related Resources & Content
